Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients with human immunodeficiency virus (HIV) co-infection. MDR-TB treatment is increasingly available, but outcomes have not been well characterized. South Africa has provided MDR-TB treatment for a decade,...
Main Authors: | Jason E Farley, Malathi Ram, William Pan, Stacie Waldman, Gail H Cassell, Richard E Chaisson, Karin Weyer, Joey Lancaster, Martie Van der Walt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3142109?pdf=render |
Similar Items
-
Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa.
by: Jason E Farley, et al.
Published: (2014-01-01) -
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
by: Martha Van der Walt, et al.
Published: (2013-01-01) -
Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.
by: Martie van der Walt, et al.
Published: (2016-01-01) -
Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01) -
Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
by: Finlay Alyssa, et al.
Published: (2012-01-01)